Latest News for Fluidra Stock (OTC:FLUIF)

Fluidra SA is engaged in the business of pool and wellness and Irrigation, Industrial, and Others. The company is responsible for manufacturing and distributing all the components required for the construction, renovation, improvement, and maintenance of residential and commercial pools. Also, in some southern European countries, the company supplements its core pool and wellness business with irrigation and landscaping accessories for gardens that are often adjacent to pools The Business Divisions of the company are EMEA, North America, and APAC.

News

Intraday Update

Markets

Movers

Trading Ideas

AFGC

AHPI

BKUH

BSTG

CODX

CZBS

DAVA

ENGQF

FLUIF

FNRN

GILD

GYST

INSU

IVME

KRMD

LAKE

LONCF

MCRPF

Blackrock Muniholdings Investment Quality Fund

MRNA

NDLS

NSTG

PDCO

PFRCF

PXYN

REGN

SWPRF

TDOC

WFRSF

WHLKY

XFLS

PPLXF

Stocks That Hit 52-Week Highs On Thursday

Fluidra SA

WIIM

UUUU

Shares of uranium stocks are trading higher after the US Senate approved a bill to ban Russian uranium imports.

AUPH

Aurinia Pharmaceuticals Announced Several Initiatives To Improve Understanding Of The Seriousness Of Lupus Nephritis And The Need For Frequent Screening And Appropriate Management

BYON

Beyond Announced Its Partnership With Extend To Offer Customers Modern Shipping And Product Protection

Ares Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCC#NASDAQ">ARCC</a>) reported quarterly earnings of $0.59 per share which missed the analyst consensus estimate of $0.60 by 1.67 percent. This is a 3.51 percent increase over earnings of $0.57 per share from the same period last year. The company reported quarterly sales of $701.000 million which beat the analyst consensus estimate of $700.133 million by 0.12 percent. This is a 13.43 percent increase over sales of $618.000 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

ARCC

Ares Capital Q1 2024 Adj EPS $0.59 Misses $0.60 Estimate, Sales $701.000M Beat $700.133M Estimate

Raymond James analyst Ric Prentiss upgrades American Tower (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMT#NYSE">AMT</a>) from Outperform to Strong Buy and raises the price target from $226 to $248.

Upgrades

Price Target

Analyst Ratings

Raymond James Upgrades American Tower to Strong Buy, Raises Price Target to $248

Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) announced that its generative AI business has reached a "multibillion-dollar" revenue run rate, during the <a href="https://www.benzinga.com/news/earnings/24/04/38534302/amazon-q1-earnings-highlights-revenue-beat-eps-beat-aws-hits-100-billion-annual-run-rate-and-more">post-Q1 earnings call</a> on Tuesday.
What Happened: Amazon CEO Andy Jassy revealed the significant achievement during the company&#8217;s Q1 2024 earnings call.
The company&#8217;s generative AI business has been witnessing robust demand, with customers expressing interest in leveraging AI to transform their businesses and enhance customer experiences, Jassy said on the call.
Amazon's cloud computing business, Amazon Web Services (AWS,) is already growing faster than the company as a whole – AWS revenue surged 17% year-on-year in Q1 2024, while overall revenue grew 13%.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Now, Amazon has revealed that its AWS business is getting another boost thanks to generative AI. Its enterprise customers are "quite excited" about leveraging this leading-edge technology.
"Our AWS customers are also quite excited about leveraging gen AI to change the customer experiences and businesses. We see considerable momentum on the AI front where we&#8217;ve accumulated a multibillion-dollar revenue run rate already," Jassy said.
Amazon CFO Brian Olsavsky echoed Jassy's sentiments, adding, "We are seeing strong demand signals from our customers and longer deals and larger commitments, many with generative AI components."
See Also: <a href="https://www.benzinga.com/news/24/04/38521828/jensen-huangs-initial-nvidia-pitch-dubbed-one-of-the-worst-by-former-boss-yet-backed-by-belief-in-go">Jensen Huang&#8217;s Initial Nvidia Pitch Dubbed &#8216;One Of The Worst&#8217; By Former Boss, Yet Backed By Belief In &#8216;Godfather Of GPU&#8217;</a>
He added that going forward, this will further fuel capital expenditure growth – Amazon spent $14 billion in capex in Q1 2024, and Olsavsky expects it to be the "low quarter for the year."
"Those signals are giving us confidence in our expansion of capital in this area."
Why It Matters: The announcement comes on the heels of Amazon&#8217;s strong Q1 2024 earnings, where the company reported a <a href="https://www.benzinga.com/news/earnings/24/04/38534302/amazon-q1-earnings-highlights-revenue-beat-eps-beat-aws-hits-100-billion-annual-run-rate-and-more">revenue beat</a> and its AWS segment hitting a <a href="https://www.benzinga.com/news/24/04/38539518/amazons-andy-jassy-remains-bullish-on-aws-sees-very-large-opportunity-and-expects-meaningful-capex-i">$100 billion annual run rate</a>.
AWS's trailing 12-month revenue, at $94.4 billion, is higher than the revenue of 466 companies in the S&amp;P 500 index. Tesla Inc. CEO <a href="https://www.benzinga.com/news/24/05/38542692/tesla-ceo-elon-musk-is-impressed-by-the-fact-that-jeff-bezos-aws-12-month-revenue-is-higher-than-466">Elon Musk </a><a href="https://www.benzinga.com/news/24/05/38542692/tesla-ceo-elon-musk-is-impressed-by-the-fact-that-jeff-bezos-aws-12-month-revenue-is-higher-than-466">expressed surprise</a> at this, saying, "Wow."
Jassy also expressed optimism about the future of AWS, highlighting the potential for AWS and the rise of gen AI, which is expected to be predominantly cloud-based over the next 10 to 20 years, presenting a significant opportunity for AWS.
Price Action:&nbsp;At the time of writing, Amazon&#8217;s shares were up 2.45% in premarket trading on Wednesday, after closing at $175 on Tuesday, according to&nbsp;<a href="https://pro.benzinga.com/dashboard" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:&nbsp;<a href="https://www.benzinga.com/news/24/04/38422652/jensen-huang-hand-delivers-nvidias-first-dgx-h200-gpu-to-openais-sam-altman-to-advance-ai-computing" target="_blank" rel="noreferrer noopener">Jensen Huang Hand-Delivers Nvidia&#8217;s First DGX H200 GPU To OpenAI&#8217;s Sam Altman To ‘Advance AI, Computing, And Humanity&#8217;</a>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Equities

Tech

AMZN

Amazon Says Generative AI Is Now A 'Multibillion-Dollar' Revenue Run Rate Business: 'Strong Demand Signals, Longer Deals, Larger Commitments' To Fuel Capex Growth

GOLD

Barrick Gold Announced That Its Subsidiary Barrick Gold Ltd. Has Entered Into An Exploration Earn-in Agreement With Geophysx Jamaica Ltd. With Respect To Certain Properties Located In Jamaica

TSLA

Tesla shares are trading lower. CEO Elon Musk on Tuesday said the company still plans to grow the Supercharger network but at a slower place for new locations to focus on 100% uptime and expansion of existing locations.

CART

Instacart Expanded Omnichannel Partnership With The Save Mart Companies

GSK shares are trading higher as the company reported better-than-expected Q1 results and raised its 2024 core operating profit guidance.

HC Wainwright &amp; Co. analyst Swayampakula Ramakanth initiates coverage on Cyclo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYTH#NASDAQ">CYTH</a>) with a Buy rating and announces Price Target of $3.

Initiation

CYTH

HC Wainwright & Co. Initiates Coverage On Cyclo Therapeutics with Buy Rating, Announces Price Target of $3

DuPont de Nemours shares are trading higher after the company reported better-than-expected Q1 financial results and raised FY24 outlook.

Management

HITI

High Tide Announced The Appointment Of Mayank Mahajan For The Role Of Chief Financial Officer

Cenovus Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVE#NYSE">CVE</a>) reported quarterly earnings of C$0.62 per share which beat the analyst consensus estimate of C$0.53 by 16.98 percent. This is a 93.75 percent increase over earnings of C$0.32 per share from the same period last year. The company reported quarterly sales of C$13.400 billion which missed the analyst consensus estimate of $14.134 billion by 5.19 percent. This is a 47.74 percent increase over sales of C$9.070 billion the same period last year.

Cenovus Energy Q1 2024 GAAP EPS C$0.62 Beats C$0.53 Estimate, Sales C$13.400B Miss C$14.134B Estimate

Second Quarter And Full Year 2024 Outlook
<table border="1" cellspacing="0" style="width:100%">
<tbody>
<tr>
<td style="text-align:left; vertical-align:middle">(in millions, except %&#39;s and per share data)</td>
<td colspan="2">Projection</td>
</tr>
<tr>
		</tr>
<tr>
<td>Item</td>
<td>Q2 2024</td>
<td>FY 2024</td>
</tr>
<tr>
		</tr>
<tr>
<td style="text-align:left; vertical-align:middle">Net Sales YoY%</td>
<td>3% - 5%</td>
<td style="text-align:center; vertical-align:middle">+LSD</td>
</tr>
<tr>
<td style="text-align:left; vertical-align:middle">Adjusted EBITDA</td>
<td>~$275</td>
<td>$1,050 - $1,080</td>
</tr>
<tr>
<td style="text-align:left; vertical-align:middle">Adjusted Diluted EPS</td>
<td>~$0.50</td>
<td>$1.90 - $2.00</td>
</tr>
<tr>
<td style="text-align:left; vertical-align:middle">Free Cash Flow</td>
<td>$425 - $475</td>
</tr>
<tr>
<td style="text-align:left; vertical-align:middle">D&amp;A (step-up D&amp;A)</td>
<td>~$280 ($50)</td>
</tr>
<tr>
<td style="text-align:left; vertical-align:middle">Tax Rate, As Adjusted</td>
<td>~25%</td>
</tr>
<tr>
<td style="text-align:left; vertical-align:middle">Diluted Shares Outstanding</td>
<td style="text-align:center; vertical-align:middle">~222</td>
</tr>
<tr>
<td style="text-align:left; vertical-align:middle">Interest Expense</td>
<td>~$210</td>
</tr>
<tr>
<td style="text-align:left; vertical-align:middle">Capex</td>
<td>~$165</td>
</tr>
</tbody>
</table>
LSD= low single digit

Guidance

AXTA

Axalta Coating Raises FY24 Adj EPS Outlook To $1.90 - $2.00, Up From $1.80 - $1.95 Prior, Vs. $1.89 Estimate

LivaNova now expects revenue for full-year 2024 to grow between 6 and&nbsp;7 percent&nbsp;on a constant-currency basis. When excluding the impact of the ACS segment wind down, the Company now expects revenue for full-year 2024 to grow between 8 and&nbsp;9 percent&nbsp;on a constant-currency basis. Foreign currency is now expected to be a&nbsp;1 percent&nbsp;headwind based on current exchange rates.
Adjusted diluted earnings per share for 2024 are now expected to be in the range of&nbsp;$3.05&nbsp;to&nbsp;$3.15, assuming a share count of approximately 55 million for full-year 2024. In 2024, the Company continues to estimate that adjusted free cash flow will be in the range of&nbsp;$95&nbsp;to&nbsp;$115 million.

LIVN

LivaNova Raises FY24 Adjusted EPS In The Range Of $3.05-$3.15 Vs. $3 Estimate (Prior View: $2.95-$3.05); Expects Revenue To Grow Between 8%-9% On Constant-currency Basis (Prior View: 4%-5%)

AMAT

MCHP

MRVL

NVDA

NXPI

Shares of semiconductor stocks are trading lower in sympathy with AMD and Supermicro, which fell after reporting quarterly earnings. Additionally, Skyworks issued Q3 revenue guidance with a midpoint below estimates.

NAPA

The Duckhorn Portfolio Announced Q3 Preliminary Net Sales Of $91M-$93M Vs. $102.4M

Health Care

General

ENSG

The Ensign Group Acquires Long-term Acute Care Hospital And Skilled Nursing Facility In Utah And Skilled Nursing Facility In Iowa; Deal Terms Not Disclosed

The Ensign Group Acquires Healthcare Campuses In Arizona And Kansas; Deal Terms Not Disclosed

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for Fluidra Stock (OTC:FLUIF)

Thursday, February 27, 2020